Prognosis prediction of thrombelastography in patients undergoing percutaneous coronary intervention

Meixiu GU,Lin SUN,Beili WANG,Xiaoci REN,Ke YAO,Wei GUO,Baishen PAN
DOI: https://doi.org/10.3969/j.issn.1673-8640.2015.06.006
IF: 1.865
2015-01-01
Laboratory Medicine
Abstract:Objective To evaluate the prognosis prediction of thrombelastography ( TEG ) in patients undergoing percutaneous coronary intervention (PCI).Methods The data from 115 patients undergoing PCI were collected , and the patients were classified into 2 groups according to maximum amplitude-adenosine diphosphate ( MA-ADP ) , MA-MDP<50 mm group and MA-ADP≥50 mm group.The percentages of adverse cardiovascular events , reinfarction and restenosis were followed up for 1 year.Results There was no statistical significance in the clinical characteristics of the 2 groups (P>0.05).Logistic regression analysis showed that MA-ADP was the risk factor of adverse cardiovascular event recurrence in patients undergoing PCI ( OR =3.547, 95% CI: 1.103-11.412, P =0.034).Compared with MA-ADP normal patients (<50 mm) , the incidences of adverse cardiovascular events and reinfarction in patients with high MA-ADP (≥50 mm) significantly increased (P<0.05).Conclusions MA-ADP can predict the prognosis after PCI.MA-ADP=50 can be the cut-off point in the prognosis prediction of patients undergoing PCI .
What problem does this paper attempt to address?